55 A phase I study of SB-715992, a novel kinesin spindle protein (KSP) inhibitor: pharmacokinetic (PK)/pharmacodynamic (PD) modeling of absolute neutrophil counts (ANC)

Authors :: E. Rowinsky
Lini Pandite
P. Mudd
G. Wilding
D. Williams
S. Kathman
J. Herendeen
K. D. Holen
J. Orr
Quincy Chu
Source :: European Journal of Cancer Supplements. 2:20-21
Publication Year :: 2004
Publisher :: Elsevier BV, 2004.

Subjects :: Cancer Research
Oncology
Pharmacokinetics
Chemistry
Pharmacodynamics
Kinesin
Pharmacology
Phase i study

Full Text Access

Tools